Kelly Lorraine Graham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Internal Medicine | 6 | 2024 | 1050 | 1.420 |
Why?
|
Patient Readmission | 6 | 2019 | 3265 | 1.230 |
Why?
|
Internship and Residency | 8 | 2024 | 5885 | 1.100 |
Why?
|
Academic Medical Centers | 6 | 2024 | 2756 | 0.890 |
Why?
|
Lost to Follow-Up | 1 | 2022 | 123 | 0.740 |
Why?
|
Physicians, Primary Care | 1 | 2024 | 619 | 0.560 |
Why?
|
Problem-Based Learning | 1 | 2019 | 356 | 0.500 |
Why?
|
Physicians | 2 | 2022 | 4584 | 0.440 |
Why?
|
Ambulatory Care | 1 | 2024 | 2770 | 0.420 |
Why?
|
Educational Measurement | 1 | 2019 | 1250 | 0.390 |
Why?
|
Leadership | 1 | 2020 | 1385 | 0.360 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2374 | 0.350 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2010 | 410 | 0.300 |
Why?
|
Primary Health Care | 5 | 2024 | 4678 | 0.270 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 934 | 0.250 |
Why?
|
Program Evaluation | 1 | 2013 | 2489 | 0.240 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.200 |
Why?
|
Breast | 1 | 2010 | 1964 | 0.190 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.170 |
Why?
|
Time Factors | 5 | 2019 | 39957 | 0.150 |
Why?
|
Quality of Health Care | 1 | 2013 | 4320 | 0.150 |
Why?
|
Patient Care | 1 | 2022 | 623 | 0.130 |
Why?
|
Faculty, Medical | 1 | 2024 | 1205 | 0.120 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 9416 | 0.120 |
Why?
|
Humans | 18 | 2024 | 761208 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1069 | 0.110 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 386 | 0.100 |
Why?
|
Qualitative Research | 1 | 2022 | 3024 | 0.090 |
Why?
|
Primary Prevention | 1 | 2017 | 1185 | 0.090 |
Why?
|
Adult | 6 | 2024 | 221119 | 0.080 |
Why?
|
Cohort Studies | 2 | 2024 | 41496 | 0.080 |
Why?
|
Medicare | 2 | 2018 | 6773 | 0.080 |
Why?
|
Male | 8 | 2024 | 360693 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3354 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2018 | 1186 | 0.080 |
Why?
|
Aged | 5 | 2024 | 169288 | 0.070 |
Why?
|
Female | 8 | 2024 | 392544 | 0.070 |
Why?
|
Nitrites | 1 | 2008 | 156 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2164 | 0.070 |
Why?
|
Middle Aged | 6 | 2024 | 220853 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2023 | 80674 | 0.070 |
Why?
|
United States | 3 | 2022 | 72339 | 0.070 |
Why?
|
Aspirin | 1 | 2017 | 3129 | 0.060 |
Why?
|
Epithelium | 1 | 2010 | 1603 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2746 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2015 | 1796 | 0.060 |
Why?
|
Cost of Illness | 1 | 2015 | 1936 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2017 | 58952 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2317 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3320 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 582 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2010 | 20982 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2208 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3441 | 0.050 |
Why?
|
Medicaid | 1 | 2015 | 2813 | 0.050 |
Why?
|
Length of Stay | 1 | 2015 | 6417 | 0.050 |
Why?
|
Risk Factors | 2 | 2018 | 74239 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 42224 | 0.040 |
Why?
|
Pravastatin | 1 | 2017 | 392 | 0.030 |
Why?
|
Prospective Studies | 1 | 2018 | 54435 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15520 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1141 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3608 | 0.020 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 968 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1116 | 0.020 |
Why?
|
Cathepsin D | 1 | 2008 | 59 | 0.020 |
Why?
|
Anions | 1 | 2008 | 133 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2008 | 543 | 0.020 |
Why?
|
COS Cells | 1 | 2008 | 1129 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2008 | 1129 | 0.010 |
Why?
|
Amino Acids | 1 | 2008 | 1703 | 0.010 |
Why?
|
Estradiol | 1 | 2008 | 1937 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5748 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5773 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24021 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16952 | 0.010 |
Why?
|
Animals | 1 | 2008 | 168079 | 0.000 |
Why?
|